There are 2789 resources available
764P - Survey on the practical implementation of BRCA gene and HRD-testing and PARP-inhibitor management in Germany: A national NOGGO/JAGO-AGO intergroup study
Presenter: Joanna Baum
Session: ePoster Display
765P - Prognosis of BRCA1 and BRCA2 ovarian cancer: Prospective follow-up data from a multidisciplinary program
Presenter: Pedro Antunes Meireles
Session: ePoster Display
812P - Demographics and survival outcomes in patients with advanced or recurrent endometrial cancer (EC) following platinum-based doublet (PBD) in the English real-world (RW) setting
Presenter: Craig Knott
Session: ePoster Display
767P - Retrospective analysis of the impact of bevacizumab dose-intensity on the survival of platinum-resistant ovarian cancer patients
Presenter: Jose Bahena
Session: ePoster Display
768P - P-cadherin prognostic significance in high-grade serous ovarian cancer wildtype for BRCA1/2
Presenter: Rita Canario
Session: ePoster Display
769P - Urinary microRNAs as biomarkers for early detection of ovarian cancer
Presenter: Shinichi Tate
Session: ePoster Display
770P - Wild-type BRCA1/2 ovarian cancer: Prospective follow-up data from a multidisciplinary program
Presenter: Inês Oliveira
Session: ePoster Display
771P - Mutational landscape and clonal evolution of coexisting ovarian cancer and borderline tumor
Presenter: Lei Li
Session: ePoster Display
772P - Hormonal therapy in pretreated patients with metastatic or refractory ovary granulosa cell tumor
Presenter: Izzet Dogan
Session: ePoster Display
817TiP - GYNET study - Safety and efficacy of anti-netrin 1 (NP137) in combination with chemotherapy and/or pembrolizumab in patients (pts) with pretreated locally advanced/metastatic endometrial carcinoma or cervix carcinoma: An adaptive multi-arms randomized phase I/II trial
Presenter: Isabelle Ray-Coquard
Session: ePoster Display